CD34-cell selection according to the good manufacturing practice.

被引：0
|
作者：
Arseniev, L
Schwender, J
Drexler, K
Schmidt-Thomssen, A
Goudeva, L
Heuft, HG
Sykora, RW
Ganser, A
Hertenstein, B
机构：
[1] Hannover Med Sch, Dept Hematol, D-3000 Hannover, Germany
[2] Hannover Med Sch, Dept Pediat Hematol, D-3000 Hannover, Germany
[3] Hannover Med Sch, Dept Transfus Med, D-3000 Hannover, Germany
[4] Cytonet Hannover GmbH, Hannover, Germany
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5131
引用
收藏
页码：320B / 320B
页数：1
相关论文
共 50 条
  • [1] CD34-cell selection from fresh and frozen-thawed cell suspensions according to the GMP-Guidelines
    Schwender, J
    Drexler, K
    Schmidt-Thomssen, A
    Goudeva, L
    Heuft, HG
    Sykora, KW
    Ganser, A
    Hertenstein, B
    Arseniev, L
    BONE MARROW TRANSPLANTATION, 2001, 27 : S134 - S134
  • [2] Transplantation of autologous peripheral blood progenitor cells: Impact of CD34-cell selection on immunological reconstitution
    Rutella, S
    Pierelli, L
    Sica, S
    Rumi, C
    Leone, G
    LEUKEMIA & LYMPHOMA, 2001, 42 (06) : 1207 - 1220
  • [3] Selection of CD34-positive blood cells for allogeneic transplantation:: Approaches to optimize CD34-cell recovery, purity, viability, and T-cell depletion
    Fritsch, G
    Scharner, D
    Fröschl, G
    Buchinger, P
    Peters, C
    Matthes, S
    Witt, V
    Gadner, H
    ONKOLOGIE, 2000, 23 (05): : 449 - 456
  • [4] Production of stem-cell transplants according to good manufacturing practice
    Bosse, R
    Kulmburg, P
    von Kalle, C
    Engelhardt, M
    Dwenger, A
    Rosenthal, F
    Schulz, G
    ANNALS OF HEMATOLOGY, 2000, 79 (09) : 469 - 476
  • [5] Production of stem-cell transplants according to good manufacturing practice
    R. Bosse
    P. Kulmburg
    C. von Kalle
    M. Engelhardt
    A. Dwenger
    F. Rosenthal
    G. Schulz
    Annals of Hematology, 2000, 79 : 469 - 476
  • [6] Quality assurance system in haemapheresis according to current good manufacturing practice
    Moog, R
    Müller, N
    TRANSFUSION SCIENCE, 1999, 20 (01): : 79 - 81
  • [7] An Interleukin-5 mutant (E12K) attenuates CD34-cell proliferation and differentiation to eosinophils
    Sjöstrand, M
    McKinnon, M
    Johnson, M
    Lötvall, J
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A33 - A33
  • [8] High leukapheresis component Cd34+ cell purity improves CD34+ cell purity following CD34+ cell selection.
    Webb, IJ
    Jiroutek, M
    Cohen, CA
    Schott, DM
    Doss, D
    Freeman, A
    Ritz, J
    Schlossman, RL
    Anderson, KC
    TRANSFUSION, 1998, 38 (10) : 46S - 46S
  • [9] Allogeneic Stem Cell Transplantation with CD34+ Cell Selection
    Elisa Roldan
    Miguel Angel Perales
    Pere Barba
    Clinical Hematology International, 2019, 1 (3) : 154 - 160
  • [10] Good manufacturing practice production of CD34+ progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemia
    de Jonge, P. K. J. D.
    van Hauten, P. M. M.
    Janssen, L. D.
    de Goede, A. L.
    Berrien-Elliott, M. M.
    van der Meer, J. M. R.
    Mousset, C. M.
    Roeven, M. W. H.
    Foster, M.
    Blijlevens, N.
    Hobo, W.
    Fehniger, T. A.
    Jansen, J. H.
    Schaap, N. P. M.
    Dolstra, H.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (10) : 3323 - 3335
12345